article thumbnail

Hospitals: Do You Know Where Your Controlled Substances Are?

The FDA Law Blog

Houck — Employee diversion of controlled substances from hospitals has been an issue since at least 1986 when I became a diversion investigator with the Drug Enforcement Administration (“DEA”). The Kentucky hospital resolved the allegations for $4,394,600 and entered into a three-year MOA in November 2021.

article thumbnail

Cutting the carbon costs of cytotoxic drug production

Hospital Pharmacy Europe

A recent study assessing the carbon footprint of a hospital pharmacys cytotoxic drug production unit and its main sources of greenhouse gas (GHG) emissions has revealed potential areas for improvement to reduce its global warming impact. Carbon footprint of a chemotherapy production unit within a hospital pharmacy: Time for green pharmacy.